Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

66 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A phase II study of weekly vinorelbine and trastuzumab in patients with HER2-positive metastatic breast cancer.
Bayo-Calero JL, Mayordomo JI, Sánchez-Rovira P, Pérez-Carrión R, Illaramendi JJ, García-Bueno JM, González-Flores E, Crespo C, Ramos-Vázquez M, García-Palomo A, Ruiz-Borrego M, de la Haba J, Gómez-Bernal A, Yubero-Esteban A. Bayo-Calero JL, et al. Clin Breast Cancer. 2008 Jun;8(3):264-8. doi: 10.3816/CBC.2008.n.030. Clin Breast Cancer. 2008. PMID: 18650157 Clinical Trial.
Beyond cancer treatment: dermo-aesthetic and other wellness recommendations for breast cancer patients.
Falcón González A, Gallegos Sancho MI, González Flores E, Galve Calvo E, Ruiz Vozmediano J, Domingo García P, López Martos R, Sánchez Rivas E, Iglesias Urraca CM, Gómez Calvo AI, De Mariscal Polo A, Ramos-Medina R, Rivero M, Martínez Marín V. Falcón González A, et al. Among authors: gonzalez flores e. Clin Transl Oncol. 2024 Aug 29. doi: 10.1007/s12094-024-03636-9. Online ahead of print. Clin Transl Oncol. 2024. PMID: 39210207
Elderly patients with advanced colorectal cancer derive similar benefit without excessive toxicity after first-line chemotherapy with oxaliplatin-based combinations: comparative outcomes from the 03-TTD-01 phase III study.
Sastre J, Aranda E, Massutí B, Tabernero J, Chaves M, Abad A, Carrato A, Reina JJ, Queralt B, Gómez-España A, González-Flores E, Rivera F, Losa F, García T, Sanchez-Rovira P, Maestu I, Díaz-Rubio E. Sastre J, et al. Crit Rev Oncol Hematol. 2009 May;70(2):134-44. doi: 10.1016/j.critrevonc.2008.11.002. Epub 2008 Dec 25. Crit Rev Oncol Hematol. 2009. PMID: 19111473 Clinical Trial.
Biochemotherapy in the treatment of metastatic melanoma in selected patients.
González Astorga B, Jiménez Rubiano B, Delgado Pérez JR, Valdivia Bautista J, Sánchez Toro C, González Flores E, Luque Caro R, Castellón Rubio V. González Astorga B, et al. Clin Transl Oncol. 2009 Jun;11(6):382-6. doi: 10.1007/s12094-009-0372-4. Clin Transl Oncol. 2009. PMID: 19531453 Review.
Phase III study to evaluate patient's preference of subcutaneous versus intravenous trastuzumab in HER2-positive metastatic breast cancer patients: Results from the ChangHER study (GEICAM/2012-07).
Ciruelos EM, Montaño A, Rodríguez CA, González-Flores E, Lluch A, Garrigós L, Quiroga V, Antón A, Malón D, Chacón JI, Velasco M, Gonzalez-Cortijo L, Jolis L, Echarri MJ, Muñoz M, Pascual T, Amigo Y, Casas M, Carrasco E, Casas A. Ciruelos EM, et al. Eur J Cancer Care (Engl). 2020 Jul;29(4):e13253. doi: 10.1111/ecc.13253. Epub 2020 Jun 23. Eur J Cancer Care (Engl). 2020. PMID: 32578279 Clinical Trial.
Real-world experience with pertuzumab and trastuzumab combined with chemotherapy in neoadjuvant treatment for patients with early-stage HER2-positive breast cancer: the NEOPERSUR study.
Falcón González A, Cruz Jurado J, Llabrés Valenti E, Urbano Cubero R, Álamo de la Gala MC, Martínez Guisado MA, Álvarez Ambite R, Rodríguez González CJ, Amérigo Góngora M, Rodríguez Pérez L, López Álvarez P, Sánchez Rovira P, González Flores E, Henao Carrasco F, Bayo Calero J, Valero Arbizu M, Quílez Cutillas A, Salvador Boffil J, Rubio Pérez E, Ruiz-Borrego M. Falcón González A, et al. Among authors: gonzalez flores e. Clin Transl Oncol. 2024 Sep;26(9):2217-2226. doi: 10.1007/s12094-024-03440-5. Epub 2024 Mar 28. Clin Transl Oncol. 2024. PMID: 38538968 Free PMC article.
Phase III study of capecitabine plus oxaliplatin compared with continuous-infusion fluorouracil plus oxaliplatin as first-line therapy in metastatic colorectal cancer: final report of the Spanish Cooperative Group for the Treatment of Digestive Tumors Trial.
Díaz-Rubio E, Tabernero J, Gómez-España A, Massutí B, Sastre J, Chaves M, Abad A, Carrato A, Queralt B, Reina JJ, Maurel J, González-Flores E, Aparicio J, Rivera F, Losa F, Aranda E; Spanish Cooperative Group for the Treatment of Digestive Tumors Trial. Díaz-Rubio E, et al. J Clin Oncol. 2007 Sep 20;25(27):4224-30. doi: 10.1200/JCO.2006.09.8467. Epub 2007 Jun 4. J Clin Oncol. 2007. PMID: 17548839 Clinical Trial.
66 results